Viewing Study NCT07008469

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2026-06-08 @ 3:30 PM
Study NCT ID: NCT07008469
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-12-22
First Post: 2025-05-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
Sponsor: Avidity Biosciences, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myotonic Dystrophy 1 View
None Myotonic Disorders View
None Steinert Myotonic Dystrophy View
None Steinert Disease View
None Myotonic Dystrophy Type 1 View
None DM1 View
None Myotonic Dystrophy View
None Myotonia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myotonia View
None Myotonic Dystrophy Type 1 (DM1) View
None Dystrophy Myotonic View
None Myotonic Disorders View
None Steinert Disease View
None Steinert View
None Myotonic Muscular Dystrophy View
None HARBOR-OLE View
None Avidity Biosciences View
None Avidity View
None AOC 1001 View
None Del-desiran View
None Delpacibart etedesiran View
None HARBOR View
None DM1 View
None Myotonic Dystrophy View
None Myotonic Dystrophy 1 View